S&P 500   3,236.33 (-2.39%)
DOW   26,758.60 (-1.94%)
QQQ   265.03 (-2.73%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
S&P 500   3,236.33 (-2.39%)
DOW   26,758.60 (-1.94%)
QQQ   265.03 (-2.73%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
S&P 500   3,236.33 (-2.39%)
DOW   26,758.60 (-1.94%)
QQQ   265.03 (-2.73%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
S&P 500   3,236.33 (-2.39%)
DOW   26,758.60 (-1.94%)
QQQ   265.03 (-2.73%)
AAPL   107.83 (-3.56%)
MSFT   201.68 (-2.77%)
FB   250.10 (-1.83%)
GOOGL   1,412.54 (-3.24%)
AMZN   3,010.57 (-3.78%)
NVDA   488.42 (-3.38%)
TSLA   384.50 (-9.37%)
BABA   273.07 (-0.81%)
CGC   14.60 (-8.98%)
GE   6.13 (-1.92%)
MU   50.10 (+0.80%)
AMD   75.15 (-3.28%)
T   27.92 (-2.07%)
F   6.67 (-1.62%)
ACB   5.17 (-29.37%)
GILD   63.18 (-0.35%)
NFLX   472.07 (-3.89%)
DIS   123.41 (-2.99%)
BAC   23.36 (-2.42%)
BA   152.08 (-3.01%)
Log in
NASDAQ:GH

Guardant Health Stock Forecast, Price & News

$106.09
-1.58 (-1.47 %)
(As of 09/23/2020 03:45 PM ET)
Add
Compare
Today's Range
$105.80
Now: $106.09
$109.41
50-Day Range
$81.62
MA: $92.61
$106.67
52-Week Range
$55.90
Now: $106.09
$109.50
Volume12,896 shs
Average Volume1.04 million shs
Market Capitalization$10.55 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.6
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.17 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone855-698-8887

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.38 million
Book Value$8.50 per share

Profitability

Net Income$-75,650,000.00

Miscellaneous

Employees454
Market Cap$10.55 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$106.09
-1.58 (-1.47 %)
(As of 09/23/2020 03:45 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GH News and Ratings via Email

Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Guardant Health (NASDAQ:GH) Frequently Asked Questions

How has Guardant Health's stock price been impacted by COVID-19 (Coronavirus)?

Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GH shares have increased by 68.5% and is now trading at $106.09.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Guardant Health?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Guardant Health
.

When is Guardant Health's next earnings date?

Guardant Health is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Guardant Health
.

How were Guardant Health's earnings last quarter?

Guardant Health Inc (NASDAQ:GH) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($0.57) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.17. The business had revenue of $66.30 million for the quarter, compared to the consensus estimate of $59.18 million. Guardant Health had a negative net margin of 45.53% and a negative return on equity of 13.35%. The company's quarterly revenue was up 22.8% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.13) earnings per share.
View Guardant Health's earnings history
.

What price target have analysts set for GH?

7 equities research analysts have issued twelve-month price objectives for Guardant Health's shares. Their forecasts range from $100.00 to $130.00. On average, they anticipate Guardant Health's stock price to reach $113.00 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts' price targets for Guardant Health
.

Who are some of Guardant Health's key competitors?

What other stocks do shareholders of Guardant Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), Okta (OKTA), Alteryx (AYX), Paypal (PYPL), Shopify (SHOP), Twilio (TWLO) and Roku (ROKU).

Who are Guardant Health's key executives?

Guardant Health's management team includes the following people:
  • Mr. AmirAli Talasaz, Chairman, Pres & COO (Age 40)
  • Dr. Helmy Eltoukhy Ph.D., Co-Founder, CEO & Director (Age 40)
  • Mr. Michael J. Wiley, Chief Legal Officer (Age 44)
  • Mr. Derek A. Bertocci, Chief Financial Officer (Age 65)
  • Dr. Richard B. Lanman, Chief Medical Officer (Age 64)

When did Guardant Health IPO?

(GH) raised $200 million in an IPO on Thursday, October 4th 2018. The company issued 12,500,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers.

What is Guardant Health's stock symbol?

Guardant Health trades on the NASDAQ under the ticker symbol "GH."

Who are Guardant Health's major shareholders?

Guardant Health's stock is owned by many different retail and institutional investors. Top institutional investors include SB Investment Advisers UK Ltd. (14.12%), Vanguard Group Inc. (6.36%), Jennison Associates LLC (3.53%), Viking Global Investors LP (3.24%), Nuveen Asset Management LLC (3.02%) and Coatue Management LLC (1.58%). Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank.
View institutional ownership trends for Guardant Health
.

Which institutional investors are selling Guardant Health stock?

GH stock was sold by a variety of institutional investors in the last quarter, including SB Investment Advisers UK Ltd., Viking Global Investors LP, Coatue Management LLC, Sumitomo Mitsui Trust Holdings Inc., AlpInvest Partners B.V., Advisor Group Holdings Inc., Nicholas Investment Partners LP, and Wisconsin Capital Management LLC. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, and Timothy P Eckersley.
View insider buying and selling activity for Guardant Health
.

Which institutional investors are buying Guardant Health stock?

GH stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Nuveen Asset Management LLC, Marshall Wace LLP, Jennison Associates LLC, Bamco Inc. NY, Marshall Wace North America L.P., SeaTown Holdings Pte. Ltd., and Summit Partners Public Asset Management LLC.
View insider buying and selling activity for Guardant Health
.

How do I buy shares of Guardant Health?

Shares of GH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Guardant Health's stock price today?

One share of GH stock can currently be purchased for approximately $106.09.

How big of a company is Guardant Health?

Guardant Health has a market capitalization of $10.55 billion and generates $214.38 million in revenue each year. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Guardant Health employs 454 workers across the globe.

What is Guardant Health's official website?

The official website for Guardant Health is www.guardanthealth.com.

How can I contact Guardant Health?

Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. The company can be reached via phone at 855-698-8887.

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.